Literature DB >> 33415360

The thymus and the science of self.

Vincent Geenen1.   

Abstract

The conventional perception asserts that immunology is the science of 'discrimination' between self and non-self. This concept is however no longer tenable as effector cells of the adaptive immune system are first conditioned to be tolerant to the body's own antigens, collectively known as self until now. Only then attain these effectors the responsiveness to non-self. The acquisition of this essential state of tolerance to self occurs for T cells in the thymus, the last major organ of our body that revealed its intricate function in health and disease. The 'thymus' as an anatomical notion was first notably documented in Ancient Greece although our present understanding of the organ's functions was only deciphered commencing in the 1960s. In the late 1980s, the thymus was identified as the site where clones of cells reactive to self, termed 'forbidden' thymocytes, are physically depleted as the result of a process now known as negative selection. The recognition of this mechanism further contributed to the belief that the central rationale of immunology as a science lies in the distinction between self and non-self. This review will discuss the evidence that the thymus serves as a unique lymphoid organ able to instruct T cells to recognize and be tolerant to harmless self before adopting the capacity to defend the body against potentially injurious non-self-antigens presented in the context of different challenges from infections to exposure to malignant cells. The emerging insight into the thymus' cardinal functions now also provides an opportunity to exploit this knowledge to develop novel strategies that specifically prevent or even treat organ-specific autoimmune diseases.

Entities:  

Keywords:  Autoimmunity; Self-peptides; Self-tolerance; Self-vaccination; Thymus; Type 1 diabetes

Year:  2021        PMID: 33415360      PMCID: PMC7925502          DOI: 10.1007/s00281-020-00831-y

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  80 in total

1.  Ontogenesis and functional aspects of oxytocin and vasopressin gene expression in the thymus network.

Authors:  I Hansenne; G Rasier; C Péqueux; F Brilot; Ch Renard; C Breton; R Greimers; J-J Legros; V Geenen; H J Martens
Journal:  J Neuroimmunol       Date:  2005-01       Impact factor: 3.478

2.  Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.

Authors:  Bart O Roep; Nanette Solvason; Peter A Gottlieb; Joana R F Abreu; Leonard C Harrison; George S Eisenbarth; Liping Yu; Michael Leviten; William A Hagopian; John B Buse; Matthias von Herrath; Joanne Quan; Robert S King; William H Robinson; Paul J Utz; Hideki Garren; Lawrence Steinman
Journal:  Sci Transl Med       Date:  2013-06-26       Impact factor: 17.956

3.  Identification of neurotensin-related peptides in human thymic epithelial cell membranes and relationship with major histocompatibility complex class I molecules.

Authors:  Y Vanneste; A N Thome; E Vandersmissen; C Charlet; D Franchimont; H Martens; A M Lhiaubet; R M Schimpff; W Rostène; V Geenen
Journal:  J Neuroimmunol       Date:  1997-06       Impact factor: 3.478

Review 4.  Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes.

Authors:  Vincent Geenen; Marie Mottet; Olivier Dardenne; Hamid Kermani; Henri Martens; Jean-Marie Francois; Moreno Galleni; Didier Hober; Souad Rahmouni; Michel Moutschen
Journal:  Curr Opin Pharmacol       Date:  2010-04-29       Impact factor: 5.547

5.  Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetes.

Authors:  O Kecha-Kamoun; I Achour; H Martens; J Collette; P J Lefebvre; D L Greiner; V Geenen
Journal:  Diabetes Metab Res Rev       Date:  2001 Mar-Apr       Impact factor: 4.876

6.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

7.  A thymus candidate in lampreys.

Authors:  Baubak Bajoghli; Peng Guo; Narges Aghaallaei; Masayuki Hirano; Christine Strohmeier; Nathanael McCurley; Dale E Bockman; Michael Schorpp; Max D Cooper; Thomas Boehm
Journal:  Nature       Date:  2011-02-03       Impact factor: 49.962

Review 8.  Regulatory T cells: mechanisms of differentiation and function.

Authors:  Steven Z Josefowicz; Li-Fan Lu; Alexander Y Rudensky
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

9.  Positional cloning of the APECED gene.

Authors:  K Nagamine; P Peterson; H S Scott; J Kudoh; S Minoshima; M Heino; K J Krohn; M D Lalioti; P E Mullis; S E Antonarakis; K Kawasaki; S Asakawa; F Ito; N Shimizu
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

10.  Dendritic cell differentiation and immune tolerance to insulin-related peptides in Igf2-deficient mice.

Authors:  Isabelle Hansenne; Chantal Renard-Charlet; Roland Greimers; Vincent Geenen
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

View more
  5 in total

Review 1.  Peptides for T cell selection in the thymus.

Authors:  Izumi Ohigashi; Mami Matsuda-Lennikov; Yousuke Takahama
Journal:  Peptides       Date:  2021-10-05       Impact factor: 3.867

2.  miR-152-3p Represses the Proliferation of the Thymic Epithelial Cells by Targeting Smad2.

Authors:  Ying Li; Xintong Wang; Qingru Wu; Fenfen Liu; Lin Yang; Bishuang Gong; Kaizhao Zhang; Yongjiang Ma; Yugu Li
Journal:  Genes (Basel)       Date:  2022-03-24       Impact factor: 4.141

3.  Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant.

Authors:  Bassel Akache; Tyler M Renner; Anh Tran; Lise Deschatelets; Renu Dudani; Blair A Harrison; Diana Duque; Julie Haukenfrers; Martin A Rossotti; Francis Gaudreault; Usha D Hemraz; Edmond Lam; Sophie Régnier; Wangxue Chen; Christian Gervais; Matthew Stuible; Lakshmi Krishnan; Yves Durocher; Michael J McCluskie
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.996

Review 4.  Multilevel mechanism of immune checkpoint inhibitor action in solid tumors: History, present issues and future development.

Authors:  Natalya Lisovska
Journal:  Oncol Lett       Date:  2022-04-29       Impact factor: 3.111

Review 5.  Psycho-Neuro-Endocrine-Immunology: A Role for Melatonin in This New Paradigm.

Authors:  Oscar K Bitzer-Quintero; Genaro G Ortiz; Socorro Jaramillo-Bueno; Elsy J Ramos-González; María G Márquez-Rosales; Daniela L C Delgado-Lara; Erandis D Torres-Sánchez; Aldo R Tejeda-Martínez; Javier Ramirez-Jirano
Journal:  Molecules       Date:  2022-07-30       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.